Apollo Endosurgery, Inc. – NASDAQ:APEN

Add to watchlist

Market closed

Open in about 12 hours

+0.50%

month

+0.91%

quarter

+67.22%

year

Market Cap	579.71M
Enterprise value	299.10M

P/E	-9.43
EV/Sales	2.65
EV/EBITDA	-6.45
Price/Sales	2.68
Price/Book	9.27
PEG ratio	0.15
EPS	-1.07

Revenue	76.85M
EBITDA	-31.61M
Income	-39.83M
Revenue Q/Q	31.80%
Revenue Y/Y	22.01%

Profit margin	-52.01%
Oper. margin	-40.1%
Gross margin	55.63%
EBIT margin	-40.1%
EBITDA margin	-41.14%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Apollo Endosurgery, Inc. (NASDAQ:APEN): Profit margin
Mar 2022	16.66M	-8.41M	-50.5%
Jun 2022	19.30M	-10.42M	-54%
Sep 2022	19.57M	-11.44M	-58.48%
Dec 2022	21.31M	-9.55M	-44.82%

Apollo Endosurgery, Inc. (NASDAQ:APEN): Earnings per share (EPS)
2022-08-02	-0.22	-0.26
2022-11-01	-0.23	-0.28

Apollo Endosurgery, Inc. (NASDAQ:APEN): Debt to assets
Mar 2022	125015000	69.98M	55.98%
Jun 2022	120762000	72.60M	60.12%
Sep 2022	116030000	73.71M	63.53%
Dec 2022	110231000	77.63M	70.43%

Apollo Endosurgery, Inc. (NASDAQ:APEN): Cash Flow
Mar 2022	-8.68M	-551K	32K
Jun 2022	-6.07M	-556K	-78K
Sep 2022	-6.19M	-1.12M	24K
Dec 2022	-10.30M	-512K	371K

Apollo Endosurgery alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Apollo Endosurgery, Inc. (NASDAQ:APEN): Employee count
Aug 2023	202
Sep 2023	202
Oct 2023	202
Nov 2023	202
Dec 2023	202
Jan 2024	202
Feb 2024	202
Mar 2024	202
Apr 2024	202
May 2024	202
Jun 2024	202
Jul 2024	202

Apollo Endosurgery
Insider Trading

Apollo Endosurgery, Inc. (NASDAQ:APEN): Insider trades (number of shares)
Period	Buy	Sel
Apr 2021	303	0
May 2021	0	74968
Aug 2021	25000	63452
Oct 2021	1367742	0
Feb 2022	30000	0
Mar 2022	10000	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	1 Mar 2022	BLACK JEFFREY G. officer: Chief Financial Officer officer: Chief Financial Officer	Common Stock	10,000	$6.2	$62,000
Purchase	28 Feb 2022	BLACK JEFFREY G. officer: Chief Financial Officer officer: Chief Financial Officer	Common Stock	15,000	$5.66	$84,900
Purchase	25 Feb 2022	BLACK JEFFREY G. officer: Chief Financial Officer officer: Chief Financial Officer	Common Stock	15,000	$5.48	$82,200
Purchase	15 Oct 2021	CPMG INC 10 percent owner 10 percent owner	Class A common stock	387,097	$7.75	$3,000,002
Purchase	15 Oct 2021	CPMG INC 10 percent owner 10 percent owner	Class A common stock	258,064	$7.75	$1,999,996
Purchase	15 Oct 2021	CPMG INC 10 percent owner 10 percent owner	Class A common stock	38,710	$7.75	$300,003
Purchase	15 Oct 2021	MCGAUGHY R KENT JR director, 10 percent owner director, 10 percent owner	Class A common stock	387,097	$7.75	$3,000,002
Purchase	15 Oct 2021	MCGAUGHY R KENT JR director, 10 percent owner director, 10 percent owner	Class A common stock	258,064	$7.75	$1,999,996
Purchase	15 Oct 2021	MCGAUGHY R KENT JR director, 10 percent owner director, 10 percent owner	Class A common stock	38,710	$7.75	$300,003
Sale	20 Aug 2021	MCKHANN CHAS	Common Stock	21,148	$7.74	$163,686

APEN insider trading transactions

Status	Patent	Filling date	Issue date
Grant	Grant Utility: Endoscopic suturing system having external instrument channel Filling date: 10 Aug 2016 Issue date: 6 Jul 2021	10 Aug 2016	6 Jul 2021
Grant	Grant Utility: Method of implanting an intragastric balloon Filling date: 9 Jul 2018 Issue date: 2 Mar 2021	9 Jul 2018	2 Mar 2021
Grant	Grant Utility: Method of endoscopic suturing Filling date: 12 Oct 2012 Issue date: 13 Oct 2020	12 Oct 2012	13 Oct 2020
Grant	Grant Utility: Endoscopic suture loop anchors and methods Filling date: 27 Oct 2016 Issue date: 5 May 2020	27 Oct 2016	5 May 2020
Grant	Grant Utility: Endoscopic suture cinch Filling date: 9 Dec 2016 Issue date: 22 Oct 2019	9 Dec 2016	22 Oct 2019

Apollo Endosurgery
Earnings Call Transcripts

Quarter	Transcript
Q3 2022 1 Nov 2022	Q3 2022 Earnings Call Transcript
Q2 2022 8 Aug 2022	Q2 2022 Earnings Call Transcript
Q1 2022 3 May 2022	Q1 2022 Earnings Call Transcript
Q4 2021 22 Feb 2022	Q4 2021 Earnings Call Transcript

APEN earnings call transcripts

Apollo Endosurgery
Executives

Insider	Age	Compensation
Mr. K. Todd Newton (1963) Consultant	62	$482,640
Mr. Bret Schwartzhoff (1973) Vice President, US Sales & Global Marketing	52	$345,980
Ms. Stefanie L. Cavanaugh (1965) Executive Officer	60	$324,160

Apollo Endosurgery
Latest News

Tuesday, 15 October 2024
12:54	Weight Loss Services Market Analysis Report 2024-2030, Featuring Profiles of Atkins Nutritionals, Precor, Apollo Endosurgery, Johnson Health Tech, Life Fitness, iFIT, Torque Fitness and More	globenewswire.com
Tuesday, 29 November 2022
18:52	APOLLO ENDOSURGERY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apollo Endosurgery, Inc. - APEN	businesswire.com
17:10	SHAREHOLDER ALERT: Weiss Law Investigates Apollo Endosurgery, Inc.	prnewswire.com
12:00	Buy-rated Boston Scientific's $615 million takeover of Apollo Endosurgery is a positive, says Needham	Market Watch
10:50	Apollo Endosurgery Stock Soars on Buyout Buzz	Schaeffers Research
07:13	Boston Scientific to acquire Apollo Endosurgery for $615 million in cash	Market Watch
Tuesday, 1 November 2022
22:18	Apollo Endosurgery, Inc. (APEN) Q3 2022 Earnings Call Transcript	Seeking Alpha
Tuesday, 18 October 2022
08:00	Apollo Endosurgery to Report Third Quarter Results on November 1, 2022	Accesswire
Monday, 8 August 2022
02:37	Apollo Endosurgery, Inc. (APEN) CEO Chas McKhann on Q2 2022 Results - Earnings Call Transcript	Seeking Alpha
Thursday, 4 August 2022
04:45	Apollo Endosurgery: Collect Shares At A Discount Following Q2 Earnings	Seeking Alpha
Thursday, 21 July 2022
08:00	Apollo Endosurgery to Report Second Quarter Results on August 2, 2022	Accesswire
Wednesday, 13 July 2022
16:15	Hot Penny Stocks to Watch Right Now? 3 For Your July List	PennyStocks
10:31	Apollo Endosurgery's New Obesity Endoscopic Systems Receive FDA Nod	Benzinga
Wednesday, 4 May 2022
16:05	This Analyst Thinks Apollo Endosurgery's Valuation 'Does Not Assign Full Value' - Read Why	Benzinga
Tuesday, 3 May 2022
23:06	Apollo Endosurgery, Inc. (APEN) CEO Chas McKhann on Q1 2022 Results - Earnings Call Transcript	Seeking Alpha
Wednesday, 13 April 2022
08:45	Apollo Endosurgery to Report First Quarter Results on May 3, 2022	Accesswire
Tuesday, 22 February 2022
20:45	Apollo Endosurgery, Inc. (APEN) CEO Charles McKhann on Q4 2021 Results - Earnings Call Transcript	Seeking Alpha
19:14	Apollo Endosurgery, Inc. (APEN) Reports Q4 Loss, Tops Revenue Estimates	Zacks Investment Research
Thursday, 10 February 2022
08:45	Apollo Endosurgery to Report Fourth Quarter and Full Year Results on February 22, 2022	Accesswire
Friday, 14 January 2022
11:35	Down 21.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Apollo Endosurgery, Inc. (APEN)	Zacks Investment Research
Monday, 3 January 2022
08:26	Apollo Endosurgery, Inc. (APEN) Moves 7% Higher: Will This Strength Last?	Zacks Investment Research
Friday, 12 November 2021
09:00	Apollo Endosurgery to Present at Four Upcoming Investor Conferences	Accesswire
Thursday, 4 November 2021
13:45	Apollo Endosurgery, Inc. (APEN) Moves to Buy: Rationale Behind the Upgrade	Zacks Investment Research
10:42	How Much Upside is Left in Apollo Endosurgery, Inc. (APEN)? Wall Street Analysts Think 35%	Zacks Investment Research
Monday, 1 November 2021
21:55	Apollo Endosurgery, Inc. (APEN) CEO Charles McKhann on Q3 2021 Results - Earnings Call Transcript	Seeking Alpha
16:59	Recap: Apollo Endosurgery Q3 Earnings	Benzinga
Friday, 29 October 2021
10:42	Apollo Endosurgery's Earnings Outlook	Benzinga
Wednesday, 27 October 2021
08:00	Apollo Endosurgery to Report Third Quarter Financial Results on November 1, 2021	Accesswire
Friday, 15 October 2021
16:05	Apollo Endosurgery Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares	Accesswire
Tuesday, 12 October 2021
23:40	Apollo Endosurgery Announces Pricing of $65 Million Public Offering of Common Stock	Accesswire

Frequently Asked Questions (FAQ)

When is Apollo Endosurgery's next earnings date?

Unfortunately, Apollo Endosurgery's (APEN) next earnings date is currently unknown.
Does Apollo Endosurgery pay dividends?

No, Apollo Endosurgery does not pay dividends.
How much money does Apollo Endosurgery make?

Apollo Endosurgery has a market capitalization of 579.71M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 22.01% to 76.86M US dollars. Apollo Endosurgery made a loss 39.84M US dollars in net income (profit) last year or -$0.28 on an earnings per share basis.
What is Apollo Endosurgery's stock symbol?

Apollo Endosurgery, Inc. is traded on the NASDAQ under the ticker symbol "APEN".
What is Apollo Endosurgery's primary industry?

Company operates in the Healthcare sector and Medical - Devices industry.
How do i buy shares of Apollo Endosurgery?

Shares of Apollo Endosurgery can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Apollo Endosurgery's key executives?
Apollo Endosurgery's management team includes the following people:
- Mr. K. Todd Newton Consultant(age: 62, pay: $482,640)
- Mr. Bret Schwartzhoff Vice President, US Sales & Global Marketing(age: 52, pay: $345,980)
- Ms. Stefanie L. Cavanaugh Executive Officer(age: 60, pay: $324,160)
How many employees does Apollo Endosurgery have?

As Jul 2024, Apollo Endosurgery employs 202 workers.
When Apollo Endosurgery went public?

Apollo Endosurgery, Inc. is publicly traded company for more then 20 years since IPO on 21 Apr 2005.
What is Apollo Endosurgery's official website?

The official website for Apollo Endosurgery is apolloendo.com.
Where are Apollo Endosurgery's headquarters?

Apollo Endosurgery is headquartered at Building 1, Austin, TX.
How can i contact Apollo Endosurgery?

Apollo Endosurgery's mailing address is Building 1, Austin, TX and company can be reached via phone at +51 22795100.

Apollo Endosurgery, Inc.

apolloendo.com

Exchange:

NASDAQ

Full time employees:

202

Industry:

Medical - Devices

Sector:

Healthcare

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

+51 22795100

Building 1
Austin, TX 78746

CIK: 0001251769
ISIN: US03767D1081
CUSIP: 03767D108